What is Progyny's acquisitions?

Progyny (PGNY) reported acquisitions of $0 in Q1 2026.

How has Progyny's acquisitions changed year-over-year?

Progyny's acquisitions decreased by 100.0% year-over-year, from $9.34M to $0.

What does acquisitions mean?

Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.

Progyny PGNY Acquisitions

Acquisitions at other companies

CVS HealthCVS

$5M-75.0%

UnitedHealth GroupUNH

$0-100%

OrganonOGN

$0-100%

Pediatrix Medical GroupMD

$7M—

Voya FinancialVOYA

$0+100%

BrightSpring Health Services, Inc.BTSG

$42.2M+525%

Other financials

Income statement

See full

Revenue$328.5M+1.4%

Gross profit$83.1M+9.6%

Operating income$35.4M+46.4%

Net income$24.2M+60.9%

EPS (diluted)$0.29+70.6%

Balance sheet

See full

Cash & equivalents$131.6M+20.5%

Total debt$27.3M-5.6%

Total equity$439.3M-6.0%

Total assets$698.3M-4.4%

Cash flow

See full

Operating cash flow$45.9M-7.7%

CapEx$6.3M+123%

Free cash flow$39.6M-15.7%

Valuation

See full

Market cap$2.11B-27.1%

Profitability

See full

Gross margin24.1%+2.1pp

Operating margin7.5%+1.4pp

Net margin5.2%+0.9pp

FCF margin14.3%-1.9pp

Returns & leverage

See full

Return on equity14.9%+4.8pp

Debt / equity0.1×0.0×

Current ratio2.1×-0.3×

Where this comes from

Reported directly by Progyny in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired.

The official record: Progyny’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Progyny's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Progyny's acquisitions?: Progyny (PGNY) reported acquisitions of $0 in Q1 2026.
How has Progyny's acquisitions changed year-over-year?: Progyny's acquisitions decreased by 100.0% year-over-year, from $9.34M to $0.
What does acquisitions mean?: Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.